Patent · US Active

Methods of making modified viral genomes

US10023845B2 · kind B2 · utility

2Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 7, 2016
Grant dateJul 17, 2018
Priority date
Expiry dateSep 7, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.